RE: Upward Trend29 Dec 2017 15:51
1.GGP - Obviously!
2.FUM - Once their MED2002 product has completed all of the current medical testing and is licensed for sale as an over the counter drug, there could be a potential "price war" between Pfizer (who will want to own it due to the impact it will have on reducing their $6bn per annum Viagra revenues) and Galaxo Smith Klein (who will want to own it to start to capture some of Pfzier's Viagra market share).
All in my own opinion though and DYOR.
(sold out to invest in GGP and just hoping the price doesn't climb too much before I can get back in with some of my GGP profits at a hugely reduced sp average)